sábado, 14 de junio de 2025
HER2+: Which First-Line Combo Wins? ++++ +++ +++
Treatment Advances & Patient Outcomes
HER2+: Which First-Line Combo Wins?
https://www.medscape.com/viewarticle/which-first-line-tx-combo-best-her2-breast-cancer-2025a1000fb8?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413
Vepdegestrant Doubles PFS vs Fulvestrant in ESR1+ Disease
https://www.medscape.com/viewarticle/which-class-er-degrader-better-er-her2-breast-cancer-2025a1000eqw?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413
Can Early Switch to Camizestrant Beat Resistance?
https://www.medscape.com/viewarticle/catching-resistance-early-can-switching-camizestrant-help-2025a1000f68?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413
Musical Toxicity After Breast Cancer Treatment
https://www.medscape.com/viewarticle/musicians-face-lasting-side-effects-after-breast-cancer-2025a1000dt5?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413
Screening & Prevention
Olive Oil Tied to Lower Breast Cancer Risk
https://www.medscape.com/viewarticle/olive-oil-may-cut-risk-specific-breast-cancer-types-2025a1000e33?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413
New Imaging Triples Dense Breast Cancer Detection
https://www.medscape.com/viewarticle/new-imaging-triples-dense-breast-cancer-detection-2025a1000d7j?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413
3D Mammography: Better for High-Risk Women?
https://www.medscape.com/viewarticle/mammography-better-women-family-history-breast-cancer-2025a1000e0o?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413
US Drug Spotlight
Abemaciclib
https://reference.medscape.com/drug/verzenio-abemaciclib-1000194?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413
Trastuzumab Deruxtecan
https://reference.medscape.com/drug/enhertu-trastuzumab-deruxtecan-4000032?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413
Sacituzumab Govitecan
https://reference.medscape.com/drug/trodelvy-sacituzumab-govitecan-1000280?ecd=mkm_ret_250614_mscpmrk_onc_breast_etid7494413&uac=148436CN&impID=7494413
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario